Analyst Price Target is $73.50
▲ +49.24% Upside Potential
This price target is based on 4 analysts offering 12 month price targets for Inogen in the last 3 months. The average price target is $73.50, with a high forecast of $75.00 and a low forecast of $72.00. The average price target represents a 49.24% upside from the last price of $49.25.
Current Consensus is
The current consensus among 4 investment analysts is to buy stock in Inogen. This rating has held steady since February 2021, when it changed from a Hold consensus rating.
Inogen, Inc. engages in the development, manufacture, and marketing of portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. Its products consists of Inogen One G4 system, Inogen One G3 system, Inogen One G5 system, Inogen TAV, and Inogen at Home. The company was founded by Alison Perry, Alison K. Bauerlein, Brenton Taylor, and Byron Myers on November 27, 2001 and is headquartered in Goleta, CA.